Latif, A., Newcombe, A., Li, S., Gilroy, K., Robertson, N. A., Lei, X., . . . Adams, P. D. (2021). BRD4-mediated repression of p53 is a target for combination therapy in AML. Nat Commun.
Citação norma ChicagoLatif, Anne-Louise, et al. "BRD4-mediated Repression of P53 Is a Target for Combination Therapy in AML." Nat Commun 2021.
ציטוט MLALatif, Anne-Louise, et al. "BRD4-mediated Repression of P53 Is a Target for Combination Therapy in AML." Nat Commun 2021.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.